The Société Française des Cancers et leucémies de l’Enfant et de l’adolescent (SFCE) has recently published a very interesting metronomic phase II in children showing the efficacy of this regimen in children with relapsing RMS. Since vinorelbine can also be given orally, this paves the way for convinient treatments. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: Good tolerance profile (...)